Biologically active peptides from functional domains of bacteric

Details Biologically active peptides from functional domains of bacteric Biologically active peptides from functional domains of bacteric

1995-06-07

1999-01-05

Davenport, Avis M.

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

25 or more amino acid residues in defined sequence

530300, 530325, 530326, 530327, 530328, 514 12, 514 13, 514 14, 514 15, A61K 3800, A61K 3802, C07K 500, C07K 700

Patent

active

058564381

ABSTRACT:
The present invention provides peptides having an amino acid sequence that is the amino acid sequence of a human bactericidal/permeability-increasing protein (BPI) functional domain or a subsequence thereof, and variants of the sequence or subsequence thereof, having at least one of the BPI biological activities, such as heparin binding, heparin neutralization, LPS binding, LPS neutralization or bactericidal activity. The invention provides peptides and pharmaceutical compositions of such peptides for a variety of therapeutic uses.

REFERENCES:
patent: 5089274 (1992-02-01), Marra et al.
patent: 5171739 (1992-12-01), Scott et al.
patent: 5198541 (1993-03-01), Elsbach et al.
patent: 5234912 (1993-08-01), Marra et al.
patent: 5308834 (1994-05-01), Scott et al.
patent: 5334584 (1994-08-01), Scott et al.
patent: 5348942 (1994-09-01), Little, II et al.
patent: 5420019 (1995-05-01), Theofan et al.
patent: 5439807 (1995-08-01), Grinna
patent: 5447913 (1995-09-01), Ammons et al.
patent: 5466580 (1995-11-01), White et al.
patent: 5466581 (1995-11-01), White et al.
patent: 5484705 (1996-01-01), White et al.
patent: 5488034 (1996-01-01), McGregor et al.
patent: 5494896 (1996-02-01), Hansbrough
patent: 5523288 (1996-06-01), Cohen et al.
patent: 5532216 (1996-07-01), Espevik et al.
patent: 5576292 (1996-11-01), Elasbach et al.
patent: 5578568 (1996-11-01), Ammons et al.
patent: 5578572 (1996-11-01), Horwitz et al.
patent: 5627153 (1997-05-01), Little, II et al.
patent: 5639727 (1997-06-01), Little, II
patent: 5643570 (1997-07-01), Theofan et al.
patent: 5643875 (1997-07-01), Friedmann et al.
patent: 5646114 (1997-07-01), Lambert
patent: 5651332 (1997-07-01), Little, II
patent: 5674834 (1997-10-01), Theofan et al.
patent: 5686414 (1997-11-01), Scannon
patent: 5696090 (1997-12-01), McGregor et al.
patent: 5703038 (1997-12-01), Ammons et al.
patent: 5731415 (1998-03-01), Gazzano-Santoro et al.
patent: 5733872 (1998-03-01), Little, II
patent: 5741779 (1998-04-01), White et al.
Appenzeller, et al., In vivo Antifungal Actibity of Optimized Domain III Peptides from Bactericidal/Permeability-Increasing Protein (BPI), Abstract/Poster #F187, 36.sup.th Interscience Conference on Antimicrobial agents and Chemotherapy, Sep. 1996, New Orleans, Louisiana.
Horwitz, et al., "Peptides from Bactericidal/Permeability-Increasing Protein (BPI) are Cytotoxic for Mycoplasma and L-forms of Gram-Postive Bacteria," Abstract/Poster #F126, 35.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1995, San Francisco, California.
Horwitz, et al., "Fungicidal Peptides from Bactericidal/Permeability-Increasing Protein (BPI) Act Synergistically with Fluconazole on Candida albicans," Abstract/Poster #F186, 36.sup.th Interscience Conference on Antimirobial Agents and Chemotherapy, Sep. 1996, New Orleans, Louisiana.
Kaufhold, et al., "Angiogenesis Inhibition by Synthetic Peptides Derived from Bactericidal/Permeability-Increasing Protein," Abstract/Poster #1786, 88.sup.th American Association for Cancer Research, Mar. 1997, San Diego, California.
Leach, et al., "Endotoxin Neutralization by Synthetic Peptides Derived from Bactericidal/Permeability-Increasing Protein (BPI)," Abstract/Poster #F122, 35.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1995, San Francisco, California.
Lim, et al., "Antimicrobial Activities of Synthetic Peptides Derived from the Functional Domains of Recombinant Bactericidal/Permeability-Increasing Protein (rBPI.sub.23)," Abstract/Poster #F138, 34rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Oct. 1994, Orlando, Florida.
Lim, et al., "Activity of Synthetic Peptides Derivred from Bactericidal/Permeability-Increasing Protein (BPI) on Antibiotic-Resistant Microbes," Abstract/Poster #F123, 35.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1995, San Francisco, California.
Lim, et al., "Fungicidal Activity of Synthetic Pepetides Derived from Bactericidal/Permeability-Increasing Protein," Abstract/Poster #F185, 36.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1996, New Orleans, Louisiana.
Little, et al., "Functional Domains of Recombinant Bactercidal/Permeability-Increasing Protein (rBPI.sub.23)," Abstract/Slide Presentation #30, 3.sup.rd Int. Congress on the Immune Consequences of Trauma, Shock and Sepsis-Mechanisms and Therapeutic Approaches, Mar. 1994, Munich, Germany.
Little, et al., "Active Peptid Constructs Derived from the Functional Domains of Bactericidal/Permeability-Increasing Protein (BPI)," Abstract/Poster #177, 14.sup.th Ameican Peptide Symposium, Jun. 1995, Columbus, Ohio.
Little, et al., "Efficacy of Novel Fungicidal Peptides Derived from the Functional Domain III of Bactericidal/Permeability-Increasing Protein (BPI)," Abstract/Poster #F121, 35.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1995, San Francisco, California.
Bauer, et al., "Pharmacokinetics of Peptides Derived from Domain III of Bactericidal/Permeability-Increasing Protein", Abstract/Poster #715, 35.sup.th Infectious Diseases Society of America Annual Meeting, Sep. 1997, San Francisco, California.
Horwitz, et al., "Fungicidal Peptides from Bactericidal/Permeability-Increasing Protein (BPI) Act Synergistically with Fluconazole on a Variety of Candida Strains", Abstract/Poster #F102, 37.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1997, Toronto, Canada.
Abrahamson, et al., "Mechanism of Action of XMP Antifungal Peptides: Factors That Influence Activity and Subcellular Localization", Abstract/Poster #C104, 37.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1997, Toronto, Canada.
Ammons, et al., "Efficacy of a Domain III-Derived Peptide from Bactericidal/Permeability-Increasing Protein (BPI) in Murine Disseminated Aspergillosis", Abstract/Presentation #B16, 37.sup.th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1997,Ttoronto, Canada.

Affiliated with

Also associated with

Rating

Biologically active peptides from functional domains of bacteric does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active peptides from functional domains of bacteric, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active peptides from functional domains of bacteric will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-863391